The PCAST report's fourth recommendation is the creation of a new pathway that manufacturers could choose to use for initial approval of drugs shown to be safe and effective in a specific subgroup of patients.
Waxman discusses a recommendation for a new drug approval pathway for specific patient subgroups.
Share
More from Henry Waxman
The House's need for all the facts surrounding suspected Presidential offences cannot of course be circumscribed by an executive determination of what is relevant.
It is not for the President to say or to obstruct congressional deliberations and investigations or other legitimate functions.
Because of the time when nothing was being done to address global warming, we are now faced with the fact that tomorrow is today.
The Federal Government would maintain its commitment to sharing the costs of providing basic healthcare and long-term coverage to vulnerable Americans.
Other voices in this conversation
